Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) just unveiled an update.
EBOS Group Limited has announced the issuance of 545,010 performance rights as part of an employee incentive scheme. These securities are unquoted and are not intended to be listed on the ASX, highlighting the company’s ongoing efforts to incentivize and retain its workforce, which could positively impact its operational efficiency and market position.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services that cater to the needs of healthcare professionals and consumers. The company focuses on delivering high-quality healthcare solutions and has a significant presence in the Australasian market.
Average Trading Volume: 145,222
Technical Sentiment Signal: Sell
Current Market Cap: A$5.3B
Find detailed analytics on EBO stock on TipRanks’ Stock Analysis page.